STRIDES PHARMA SCIENCE Plunges by 5%; BSE HEALTHCARE Index Down 1.4%
June 19, 2019 02:38 PM

STRIDES PHARMA SCIENCE share price has plunged 5% and is presently trading at Rs 416.

Meanwhile, the BSE HEALTHCARE Index is at 12,729 (down 1.4%).

Among the top losers in the BSE HEALTHCARE Index today are STRIDES PHARMA SCIENCE (down 5.1%) and PIRAMAL ENTERPRISES (down 5.2%).

BIOCON (up 2.3%) and CAPLIN POINT (up 2.3%) are among the top gainers today.

Over the last one year, STRIDES PHARMA SCIENCE has moved up from Rs 405 to Rs 416, registering a gain of Rs 11 (up 2.8%)..

The BSE HEALTHCARE has moved down from 14,312 to 12,729, loss of 1,583 points (down 11.1%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were MERCK (up 62.3%), DIVIS LABORATORIES (up 40.4%) and IPCA LABS (up 34.4%).

What About the Benchmark Indices?

The BSE Sensex is at 39,436 (down 0.1%). The top gainers among the BSE Sensex stocks today are TATA STEEL (up 2.8%). The most traded stocks in the BSE Sensex are TATA STEEL and ITC.

In the meantime, NSE Nifty is at 11,802 (down 0.3%). TATA STEEL (up 2.8%) and ZEE ENTERTAINMENT (up 2.3%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,548 to 39,436, registering a gain of 3,888 points (up 9.8%).

STRIDES PHARMA SCIENCE Financial Update...

STRIDES PHARMA SCIENCE net profit stood at Rs 650 million for the quarter ended March 2019, compared to a profit of Rs 316 million a year ago. Net Sales rose 5.7% to Rs 8.4 billion during the period as against Rs 7.9 billion in January-March 2018.

For the year ended March 2018, STRIDES PHARMA SCIENCE reported 58.6% decrease in net profit to Rs 1.3 billion compared to net profit of Rs 3.2 billion during FY17.

Revenue of the company grew 3.0% to Rs 28 billion during FY18.

The current Price to earnings ratio of STRIDES PHARMA SCIENCE, based on rolling 12 month earnings, stands at 33.4x.